BROOKLYN, NY, The Mito Fund has invested $500,000 in Pierrepont Therapeutics, Inc., a company focusing on treatments for primary mitochondrial and rare diseases. Read More
SALT LAKE CITY, UT, Leash Biosciences, an artificial intelligence native biotechnology company, announced the completion of a $9.3 million seed financing round. Read More
